7 Best Nano Cap Stocks To Invest In
In one of our recent articles about 8 Most Undervalued Penny Stocks To Buy According To Analysts, we talked about how many analysts are expecting small caps to perform well in a slowing economy.
Enanta Pharmaceuticals Inc (ENTA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 2,108,262 | $21,841,594 | +1% | 0.1% |
| 2. | Armistice Capital Steven Boyd | 1,000,000 | $10,360,000 | -9% | 0.16% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 850,890 | $8,815,221 | -9% | 0.01% |
| 4. | Soleus Capital Guy Levy | 785,546 | $8,138,257 | -2% | 0.63% |
| 5. | Millennium Management Israel Englander | 731,295 | $7,576,216 | +8% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.45 | 500 | Officer | 1,900 | 2016-05-11 | Filing | |
| $27.04 | 2,000 | Director | 15,295 | 2016-02-12 | Filing | |
| $34.20 | 600 | Director | 2,000 | 2015-02-19 | Filing | |
| $33.69 | 400 | Director | 1,400 | 2015-02-18 | Filing | |
| $33.10 | 400 | Officer | 1,400 | 2015-02-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.06 | 2,283 | Officer | 29,305 | 2024-12-06 | Filing | |
| $8.06 | 2,283 | Officer | 36,047 | 2024-12-06 | Filing | |
| $8.06 | 866 | Officer | 17,918 | 2024-12-06 | Filing | |
| $8.06 | 2,591 | Officer | 369,109 | 2024-12-06 | Filing | |
| $8.06 | 2,591 | Officer | 91,710 | 2024-12-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,934,711 | $18,205,631 | 0% | |
| 2. | 1,793,786 | $16,879,526 | 0% | |
| 3. | 1,173,058 | $11,038,481 | 0% | |
| 4. | 935,493 | $8,802,989 | 0% | |
| 5. | 583,658 | $5,492,222 | 0.01% |
News See All
Top 10 Holdings of Caligan Partners
Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to Enanta Pharmaceuticals' Fiscal Second Quarter Financial Results Conference Call. At this time, all participants are on a listen-only mode.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to Enanta Pharmaceuticals' Fiscal First Quarter Financial Results Conference Call. At this time, all participants are on a listen-only mode.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal Fourth Quarter and Year-End Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Top 5 Stock Picks of Farallon Capital
In this article, we discuss the top 5 stock picks of Farallon Capital.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Enanta Pharmaceuticals’ Fiscal Third Quarter Financial Results Conference Call. At this time, all participants are in a listen only mode.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal Second Quarter Ended March 31, 2022 Financial Results Conference Call. At this time, all participants are in a listen only mode.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal First Quarter Ended December 31, 2022 Financial Results Conference Call. At this time all participants are in a listen only mode.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal Fourth Quarter and Full Year Ended September 30, 2022 Financial Results Conference Call.